You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rhodopsin

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Retinitis Pigmentosa Trial in Ann Arbor (Hydroxychloroquine lower dose, Hydroxychloroquine higher dose)

Recruiting
  • Retinitis Pigmentosa
  • Hydroxychloroquine lower dose
  • Hydroxychloroquine higher dose
  • Ann Arbor, Michigan
    University of Michigan
Feb 14, 2022

Retinitis Pigmentosa Trial in Durham (ADX-2191)

Recruiting
  • Retinitis Pigmentosa
  • Durham, North Carolina
    Duke Eye Center
Sep 26, 2022

Retinitis Pigmentosa Trial in Pittsburgh, Paris (Ophthalmic examinations, Mobility Test)

Active, not recruiting
  • Retinitis Pigmentosa
  • Ophthalmic examinations
  • Mobility Test
  • Pittsburgh, Pennsylvania
  • +1 more
Apr 19, 2022

X-Linked Retinitis Pigmentosa Trial in Meguro-ku (AAV5-hRKp.RPGR)

Not yet recruiting
  • X-Linked Retinitis Pigmentosa
  • AAV5-hRKp.RPGR
  • Meguro-ku, Japan
    National Hospital Organization Tokyo Medical Center
Jun 23, 2023

Rod and Cone Mediated Function in Retinal Disease

Recruiting
  • Retinal Degeneration
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Retrospective Natural History Study of Retinitis Pigmentosa

    Active, not recruiting
    • Retinitis Pigmentosa (RP)
      • Paris, France
        CHNO XV-XX Paris - CIC 1423
      Aug 3, 2021

      Retinitis Pigmentosa Trial in Bangkoknoi (BM-MSC)

      Completed
      • Retinitis Pigmentosa
      • BM-MSC
      • Bangkoknoi, Bangkok, Thailand
        Siriraj Hospital Mahidol University
      Aug 31, 2021

      Choroideremia Trial in Durham (Vitamin A palmitate)

      Not yet recruiting
      • Choroideremia
      • Vitamin A palmitate
      • Durham, North Carolina
        Duke Eye Center
      Apr 8, 2022

      Retinitis Pigmentosa Trial in Worldwide (N-acetylcysteine, Placebo)

      Not yet recruiting
      • Retinitis Pigmentosa
      • Davis, California
      • +30 more
      Sep 8, 2022

      Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), Trauma, Multiple Sclerosis (MS) Trial in Philadelphia (Transcorneal

      Completed
      Has Results
      • Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
      • +2 more
      • Transcorneal Electrical Stimulation
      • Sham
      • Philadelphia, Pennsylvania
        Wills Eye Hospital
      Jan 6, 2020

      Retinitis Pigmentosa Trial in United States (Valproic Acid, Placebo)

      Completed
      Has Results
      • Retinitis Pigmentosa
      • Valproic Acid
      • Placebo
      • Miami, Florida
      • +5 more
      Oct 24, 2017

      Retinitis Pigmentosa Trial run by the NEI (Vitamin A)

      Completed
      • Retinitis Pigmentosa
      • Vitamin A
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jun 30, 2017

      Retinitis Pigmentosa Trial run by the NEI (Minocycline)

      Completed
      Has Results
      • Retinitis Pigmentosa
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Nov 1, 2017

      Retinal Degeneration, Genetic Disease, Single-Gene Defects Trial in Rome (Saffron supplementation, )

      Unknown status
      • Retinal Degeneration
      • +3 more
      • Saffron supplementation
      • placebo
      • Rome, Italy
        Policlinico A. Gemelli
      Jul 18, 2017

      Autosomal Dominant Retinitis Pigmentosa Trial in Montpellier (genetic analysis)

      Completed
      • Autosomal Dominant Retinitis Pigmentosa
      • genetic analysis
      • Montpellier, France
        CHRU Montpellier
      Nov 5, 2013

      Anterior Uveitis, Uveitis Trial run by the NEI (Interferon Gamma-1b)

      Completed
      Has Results
      • Anterior Uveitis
      • Uveitis
      • Interferon Gamma-1b
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Sep 6, 2012

      Retinitis Pigmentosa Trial run by the NEI (Ciliary Neurotrophic Factor Implant NT-501)

      Completed
      • Retinitis Pigmentosa
      • Ciliary Neurotrophic Factor Implant NT-501
      • Bethesda, Maryland
        National Eye Institute (NEI)
      Mar 3, 2008